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To determine the effects of 12 weeks of resistance exercise with MyoVive
and/or colostrum supplementation, 19 male and female recreationally weight-
trained subjects (X ± SE; age = 28.3 ± 6.9 yrs; hgt = 68.2 ± 3.8 cm) were
divided into MyoVive + colostrum (n = 4), MyoVive + casein & whey (n
= 4), colostrum + casein & whey (n = 6), and casein & whey (n = 5) groups.
All groups similarly increased (p < .05) 1 repetition maximum (RM) leg press
(kg; pre = 158.6 ± 12.8, post = 189.3 ± 11.3), body mass (kg; pre = 79.0 ±
3.2, post = 80.7 ± 3.8), and lean body mass (kg; pre = 60.1 ± 3.1, post = 62.2
± 2.8). Increases were observed for peak force (N; all loads), peak velocity
(m.s-1; 70% & 40% 1 RM), and peak power (W; 70% & 40% 1 RM) for all
groups for the leg press exercise, with no differences between groups. When
performance data were adjusted for body mass, lean body mass, lower body
lean mass as determined by DEXA, or % change, no group differences were
observed. Relative (%) fiber type content, cross-sectional areas (mm2), % fi-
ber type areas, or % myosin heavy chain expression did not change for any
group. These data suggest that MyoVive and colostrum supplementation
have no greater effect on cellular and performance adaptations when com-
pared to casein and whey protein.
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Introduction
Recent years have witnessed a meteoric increase in the use of dietary supplements
as ergogenic aids for sport performance as well as body composition regulation
(Bradley-Popovich, Stout, and Antonio 2001). Among the most popular are pro-
tein supplements, which are available in a variety of forms. Some of the most
effective forms of dietary protein supplements are casein and whey, both derived
from milk (Incledon and Antonio 2001). Whey protein is derived from the fluid
portion of milk after the coagulated portion is removed. It consists of almost 25%
of all milk proteins and provides high amounts the essential amino acids, which
include the branched-chain amino acids (Smith 1976, Smithers, Ballard, Copeland
et al. 1996). Whey protein is readily absorbed (Boirie, Dangin, Gachon et al. 1997),
and may positively affect body composition and muscular performance (Lands,
Grey, and Smountas 1999). Casein protein is precipitated from bovine milk sources
and represents over 75% of all milk proteins (Incledon and Antonio 2001). It is
readily absorbed, can increase circulating concentrations of amino acids, and en-
hances protein metabolism (Silk, Clark, Marrs et al. 1975; Jenkin, Yang, and Ander-
son 1979; Reecy, Williams, Kerley et al. 1996). Both of these forms of dietary
protein are relatively inexpensive, compared to newer dietary supplements now
being marketed.
Bovine colostrum recently has been touted as a superior form of supplemen-
tal protein. This readily absorbed source of protein is suggested to enhance lean
body mass (Antonio, Sanders, and VanGammern 2001) and enhance physical per-
formance (Brinkworth, Buckley, Bourdon et al. 2002; Buckley, Abbott, Brinkworth
et al. 2002; Coombes, Conacher, Austen et al. 2002; Hofman, Smeets, Verlaan et
al. 2002), although these data are equivocal. In addition, a potentially important
ingredient of colostrum is insulin-like growth factor-1 (IGF-1) (Ginjala and
Pakkanen 1998), and colostrum ingestion appears to elevate circulating concen-
trations of IGF-1 (Mero, Miikkulainen, Riski et al. 1997). It also has been reported
to influence the immune system via cytokines (Bocci, von Bremen, Corradeschi et
al. 1991) and to function as an antioxidant (Buescher and McIlhern 1988). Be-
cause colostrum is a critical source of dietary proteins for neonatals and has been
shown to enhance protein synthesis in young pigs (Burrin, Shulman, Reeds et al.
1992), it has been surmised that this form of protein may be an excellent source of
dietary protein for humans as well. One drawback to this product, however, is the
relatively high cost.
MyoVive is a product that has received attention as a dietary supplement
for patients with coronary arterial disease (Jeejeebhoy, Keith, Freeman et al. 2002).
The ingredients, however, include several substances that may enhance skeletal
muscle quantity or performance, or both, particularly creatine monohydrate (Nis-
sen and Sharp 2003). As such, MyoVive has been marketed as a dietary supple-
ment for the sport and exercise community. The safety and effectiveness of creat-
ine supplementation for enhancing lean mass and muscular performance are well
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documented (Bemben, Bemben, Loftiss et al. 2001; Nissen and Sharp 2003;
Schilling, Stone, Utter et al. 2001). Furthermore, creatine supplementation com-
bined with chronic resistance exercise has been shown to increase contractile pro-
tein synthesis and mRNA expression (Willoughby and Rosene 2001). Few data
are available, however, as to the effectiveness of MyoVive for enhancing lean
mass or muscular performance in humans.
It is well established that chronic resistance exercise in humans produces ad-
aptations at the cellular and molecular levels (Staron, Karapondo, Kraemer et al.
1994; Staron, Malicky, Leonardi et al. 1990). As skeletal muscle is quite plastic, it
is able to readily respond to current functional demands. For example, it has been
proposed that fiber type classifications, based on myosin ATPase (mATPase) his-
tochemistry, actually represent a continuum of fiber types that span the functional
demands of the muscular system, as illustrated below (Staron and Johnson 1993).
I « IC « IIC « IIAC « IIA « IIAB « IIB
Fiber type transitions due to exercise tend to go in the direction from type IIB
to type IIA, with little or no change to type I fibers, regardless of the modality of
exercise (Staron and Johnson 1993). Myosin heavy chain (MHC) is one of the
proteins that makes up the myosin filament, forms the cross bridge according to
the sliding filament theory, and is the site of mATPase activity. The MHC isoform
(I, IIa, or IIb) that the mature human skeletal muscle fiber contains has been shown
to significantly correlate with the relative fiber type areas (I, IIA, or IIB; Fry,
Allemeier, and Staron 1994). Furthermore, MHC isoform expression changes along
with the fiber type transitions consequent to resistance training (Fry, Allemeier,
and Staron 1994; Staron, Karapondo, Kraemer et al. 1994). The differing isoforms
with their unique mATPase activity have been found to correlate with speed of
contraction in both animals and humans, MHC I being the slowest and MHC IIb
the fastest and most powerful (Bottinelli, Betto, Schiaffino et al. 1994; Trappe,
Costill, and Thomas 2001). Because fibers containing predominantly MHC IIb
are not well suited for consistent activity, current exercise literature suggests that
these fibers convert to type IIA due to heavy resistance exercise (Fry, Allemeier,
and Staron 1994; Staron and Johnson 1993; Staron, Karapondo, Kraemer et al.
1994).
Muscular performance consequent to a resistance exercise regimen often is
assessed via tests of maximal muscular strength such as one repetition maximum
(1 RM) for the trained exercises (Kraemer and Fry 1995). Recent pilot data from
our laboratory suggested that assessments of muscular power (force x velocity)
may be more sensitive measures than 1 RM strength (unpublished data). Because
power is the product of both force and velocity, it is likely that these two variables
also may be sensitive to a training protocol, although to a lesser extent.
The purpose of the present study, therefore, was to compare the effectiveness
of MyoVive or colostrum dietary supplementation, or both, with more readily
available forms of supplemental protein (i.e., casein and whey). Variables of inter-
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est included body composition, muscular performance, and muscle fiber adapta-
tions at the cellular and molecular levels.
Methods
Design
This study utilized a prepost test design comparing four different groups. The
intervention included a heavy resistance exercise program performed by all four
groups. Independent variables were the supplements ingested during the 12-week
period. A complete test battery was performed at the beginning and end of the
study.
Subjects
Nineteen subjects (X ± SE; age = 28.3 ± 6.9 yrs; hgt = 68.2 ± 3.8 cm) were ran-
domly divided into groups ingesting MyoVive + colostrum (Myo+Col; n = 4),
MyoVive + control (Myo; n = 4), colostrum + control (Col; n = 6), and casein/
whey only (control; C + W; n = 5). Subjects included both males (n = 13) and
females (n = 6). All subjects signed an informed consent statement and completed
a health history questionnaire, as approved by the Institutional Review Board. All
subjects were currently performing regular resistance exercise training for both
the upper and lower body.
Supplementation
Each subject orally ingested daily a dietary supplement for the 12-week duration
of the study. Supplements were administered in a double-blind manner and con-
tained isocaloric doses of one of the following: MyoVive (General Nutrition
Centers, Pittsburgh, PA, U.S.) + Colostrum (Intact) (Northfield Laboratories,
Oakden, South Australia), MyoVive + control, Colostrum (Intact) + control,
and control supplement only. Casein and whey protein served as the control supple-
ment. Subjects returned empty supplement packets to verify supplementation com-
pliance. Supplement ingredients for each group are listed in Table 1.
Training Program
Each subject performed a heavy resistance exercise program 4 d.wk-1 for 12 weeks,
using a 2-day split routine (2 d upper body, 2 d lower body). Exercises for all
major muscle groups were included. Lower body sessions included leg press or
barbell squat, leg extensions, and leg curls. Upper body sessions included bench
press, shoulder press, bent-over rows, biceps curls, and triceps extensions. All
subjects performed 4 sets x 810 repetitions using approximately 10 RM loads
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Table 1
Ingredients of the Supplements Ingested by the Four Groups of Subjects
Nutrients MyoVive + MyoVive + Colostrum Casein &
Colostrum Casein & (Intact) + Whey
(Intact) Whey Casein
Whey
Protein Casein 7.5 g 43.5 g 7.5 g 43.5 g
Whey 7.5 g 31.5 g 7.5 g 31.5 g
Colostrum 60 g 60 g
Carbohydrates Lactose 1.525 g 1.525 g 1.525 g 1.525 g
Sacharose 15.1 g 15.1 g 15.1 g 15.1 g
Organic acids 0.9 g 0.9 g 0.9 g 0.9 g
Others 0.2 g 0.2 g 0.2 g 0.2 g
Fats Saturates 1.3 g 1.3 g 1.3 g 1.3 g
Monousaturates 4.4 g 4.4 g 4.4 g 4.4 g
Linoleic acid 1.73 g 1.73 g 1.73 g 1.73 g
Alpha linolenic 0.37 g 0.37 g 0.37 g 0.37 g
     acid
Minerals Na+ 108 mg 108 mg
K+ 750 mg 750 mg
Cl 203 mg 203 mg
Ca++ 315 mg 315 mg
P+ 183 mg 183 mg
Mg+ 20 mg 20 mg
Trace elements Fe 1 mg 1 mg
Zn 15 mg 15 mg
Cu 1.5 mg 1.5 mg
Mn 3.0 mg 3.0 mg
F 1.0 mg 1.0 mg
Mo 50 µg 50 µg
Se 50 µg 50 µg
Cr 33 µg 33 µg
I 100 µg 100 µg
Vitamins Vitamin A 668 µg RE 668 µg RE
Vitamin D 5 µg 5 µg
Vitamin E 538 mg a-TE 538 mg a-TE
Thiamin 25 mg 25 mg
Riboflavin 3.0 mg 3.0 mg
Niacin 20 mg NE 20 mg NE
Pantothenate 4.0 mg 4.0 mg
(Continued)
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(70%85% 1 RM). Interset rest intervals were approximately 2 min, and
interexercise rest intervals were approximately 3 min. Because training was per-
formed at numerous training sites, compliance with the program was verified by
prior arrangement with supervisory personnel at each training site. Individual ex-
ercises were modified for some subjects due to equipment limitations at some
training sites.
Body Composition
Body composition was determined using a calibrated Hologic 4500W dual energy
X-ray absorptiometer (DEXA). A three-compartment model (bone, lean, fat) was
used to determine total body and segmental body composition measures (i.e., mass,
% fat, bone-free lean mass, and fat mass). Strength measures were adjusted for
lower body mass and lower body bone-free lean mass, using the pelvis and right
and left lower limb segments.
Muscular Performance
One repetition maximum (1 RM) performance was assessed for lower body strength
using an AMF Hip Sled/Leg Press (Jefferson, IA, U.S.). The 1 RM test protocol
has been described in detail by Kraemer and Fry (1995). Reliability for 1 RM
testing in our laboratory has been established at r > 0.94 (unpublished data). A
Fitrodyne dynamometer (Bratislava, Slovakia) was interfaced with an AMF Hip
Table 1 (Continued)
Nutrients MyoVive + MyoVive + Colostrum Casein &
Colostrum Casein & (Intact) + Whey
(Intactv) Whey Casein
Whey
Vitamin B-6 6.0 mg 6.0 mg
Folate 600 µg 600 µg
Vitamin B-12 3.0 µg 3.0 µg
Biotin 100 µg 100 µg
Vitamin C 250 mg 250 mg
Other Nutrients Carnitine 3 g 3 g
Choline 100 mg 100 mg
Creatine 3 g 3 g
Taurine 3 g 3 g
Coenzyme Q-10 50 mg 50 mg
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Sled to determine peak force, peak velocity, and peak power during the leg press
exercise (see Figure 1). Loads used were 100%, 70%, and 40% of each subjects 1
RM. The subjects were instructed to accelerate the weight as fast as possible.
Wooden stops were attached to the track of the hip sled, based on each subjects
height. These allowed the subjects to move the weight as fast as possible without
the weight leaving their feet at the end of the range of motion. Reliability of the
Fitrodyne dynamometer using inanimate objects has been established at CV =
1.4% for force (N) and 0.9% for velocity (m.s-1) (unpublished data).
Muscle Biopsies
Muscle biopsies (80160 mg) were extracted from the vastus lateralis muscle,
oriented in tragacanth gum, frozen in isopentane cooled by liquid nitrogen to
159o C, and stored at 80o C (Bergstrom 1962). To ensure adequate sample sizes,
large pieces were obtained using the double-chop method combined with suction
(Evans, Pinney, and Young 1982). The frozen biopsy samples were thawed to
20o C and serially sectioned for the determination of muscle protein content (40
µm thick sections) and fiber type composition (12 µm thick sections). A mean of
1,108 fibers were obtained for each biopsy.
Figure 1. Hip sled interfaced with computerized dynamometer.
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Fiber Type Distribution
Routine myofibrillar adenosine triphosphatase (mATPase) histochemical analysis
using the methods of Brooke and Kaiser (1970) and modified for fiber subtype
analyses (Staron and Hikida 1992) were performed using preincubation pH values
of 4.3, 4.6, and 10.2 to determine the muscle fiber type distribution. Although
seven fiber types (I, IC, IIC, IIAC, IIA, IIAB, and IIB) can be distinguished based
on their staining intensities, due to the small number of some of the hybrid fibers,
types IIC and IIAC were grouped together. A composite hard copy image of each
mATPase preparation (preincubation at pH 4.6) was made using the NIH Image
software. These were used in combination with the other histochemical prepara-
tions (preincubation pH values of 4.3 and 10.6) to determine fiber type percent-
ages and total fiber number in each biopsy. The present study utilized the fiber
type classification originally developed for humans, as has been previously sug-
gested (Staron 1997).
Percentage Fiber Type Area
The cross-sectional areas of at least 50 fibers per major type (I, IIA, and IIB) per
biopsy were determined by the use of public-domain NIH software (McCall, Byrnes,
Dickson et al. 1998). Although seven fiber types may be distinguished, the hy-
brid fiber types (IC, IIC, IIAC, and IIAB) comprise such a small percentage of
the total muscle fibers that it is not possible to identify 50 of these fibers in a
typical biopsy sample (Staron and Hikida 1992). As such, fiber types areas were
determined for only the major fiber types (i.e., I, IIA, and IIB).
Myosin Heavy Chain Analysis
Myosin heavy chain (MHC) analysis was performed using SDS-polyacrylamide
gel electrophoresis (SDS-PAGE). This protocol is based on the procedures of
Carraro and Cantani (1983), and Perrie and Bumford (1986). Briefly, 35 serial
cross-sections (40 µm thick) from each biopsy were placed in 0.51.0 mL of a
lysing buffer containing 10% (w/v) glycerol, 5% (v/v) b-mercaptoethanol, and
2.3% (w/v) sodium dodecylsulfate (SDS) in 62.5 mM Tris/HCl buffer (pH 6.8)
and heated for 10 min at 60oC. Small amounts of the extracts (35 µL) were loaded
on 4%8% gradient SDS polyacrylamide gels with 4% stacking gels (12), run
overnight (1921 hr) at 120 V and stained with Coomasie blue. MHC isoforms
were identified according to their apparent molecular masses compared with those
of marker proteins and migration patterns from single fiber analysis. Relative MHC
content (%) was determined by densitometric scanning of the resulting gels
using NIH Image software. The resulting scans were further analyzed using Peakfit
software.
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Statistical Analyses
Results are reported as X ± SE. Mixed model analyses of variance were used to
determine differences between groups and across time. Significance for this in-
vestigation was p < 0.05. Where appropriate, effect sizes were analyzed to account
for potentially important results that were not significant due to low statistical
power (Cohen 1977; Vincent 1995; Wilson, Becker, Tinker 1995).
Results
Tables 27 list the physical characteristics, muscle performance, and muscle fiber
data. All groups exhibited significant increases in body mass and lean body mass,
with no differences between the group responses. In general, all groups improved
muscle force, velocity, and power due to the training program. No between-group
differences were observed (i.e., interactions). Furthermore, when performances
were adjusted for lower body mass or lower body bone-free lean mass, no be-
tween-group differences were observed. There were no significant changes for
any of the fiber or protein variables, and no differences were reported between
groups. In addition, when the data were calculated as relative changes (% D), the
results were identical (data not shown).
Discussion
The primary results of this study suggest that supplementation with either
MyoVive, colostrum, or both, do not augment resistance training-induced ad-
Table 2
Physical Characteristics (Mean ± SE)
Variable Test Myo + Col Myo + C&W Col + C&W Cas + Whey
Body mass (kg) Pre 70.2 ± 7.1 80.6 ± 7.1 82.8 ± 5.8 80.4 ± 6.3
Post* 73.2 ± 7.1 81.1 ± 7.1 84.5 ± 5.8 81.7 ± 6.3
Lean body mass Pre 54.1 ± 7.2 59.2 ± 7.2 63.2 ± 5.9 62.0 ± 6.5
Post* 59.3 ± 6.5 60.0 ± 6.5 64.5 ± 5.3 63.6 ± 5.8
Percent fat (%) Pre 15.9 ± 4.7 22.9 ± 4.7 19.8 ± 3.9 19.9 ± 4.2
Post 15.8 ± 4.2 22.6 ± 4.2 19.9 ± 3.4 19.1 ± 3.8
Note: Myo + Col = MyoVive + colostrum group (n = 4), Myo + C&W = MyoVive
+ casein & whey group (n = 4), Col + C&W = bovine colostrum + casein & whey group (n







Leg Press Performances (Mean ± SE)
Variable Load Test Myo + Col Myo + C&W Col + C&W Cas + Whey
1 RM (kg) Pre 138.3 ± 25.6 125.5 ± 25.6 185.8 ± 20.9 166.0 ± 22.9
Post* 170.3 ± 26.0 179.5 ± 26.0 204.5 ± 21.2 194.2 ± 23.3
Peak force 100% Pre 1071.6 ± 260.2 1984.0 ± 225.3 1495.7 ± 201.5 1278.5 ± 225.3
 (N) Post* 1234.0 ± 257.6 1346.6 ± 223.1 1541.5 ± 199.5 1422.2 ± 223.1
70% Pre 1758.5 ± 260.9 1731.2 ± 184.5 1105.0 ± 165.0 1941.1 ± 184.5
Post* 1057.6 ± 272.1 1072.6 ± 192.4 1218.7 ± 172.1 1213.8 ± 192.4
40% Pre 496.3 ± 183.3 429.9 ± 129.6 726.5 ± 105.8 660.5 ± 129.6
Post* 734.4 ± 186.7 683.2 ± 132.0 753.8 ± 107.8 827.2 ± 132.0
Peak velocity 100% Pre 47.7 ± 7.2 50.5 ± 6.3 52.8 ± 5.6 45.8 ± 6.3
 (cm.s-1) Post 44.8 ± 8.8 41.5 ± 7.6 35.1 ± 6.8 50.0 ± 7.6
70% Pre 70.8 ± 17.8 177.2 ± 12.6 73.3 ± 11.2 182.9 ± 12.6










40% Pre 163.6 ± 19.2 199.0 ± 13.6 115.3 ± 11.1 110.8 ± 13.6
Post* 135.7 ± 29.8 132.0 ± 21.1 197.8 ± 17.2 165.0 ± 21.1
 Peak power 100% Pre 529.1 ± 173.2 527.3 ± 150.0 799.2 ± 134.2 609.3 ± 150.0
 (W) Post 573.8 ± 195.3 615.9 ± 169.1 553.9 ± 151.3 699.5 ± 169.1
70% Pre 502.0 ± 359.4 1599.3 ± 254.1 1897.1 ± 227.3 1784.6 ± 254.1
Post* 918.7 ± 332.9 1076.0 ± 235.4 1052.5 ± 210.5 1311.5 ± 235.4
40% Pre 346.8 ± 297.7 426.3 ± 210.5 880.4 ± 171.9 1782.1 ± 210.5
Post* 979.5 ± 415.0 894.4 ± 293.4 777.4 ± 239.6 1454.6 ± 293.4
Note: Myo + Col = MyoVive + colostrum group (n = 4), Myo + C&W = MyoVive + casein & whey group (n = 4), Col + C&W = bovine
colostrum + casein & whey group (n = 6), and Cas + Whey = casein & whey only group (n = 5). Load = % one repetition maximum (1 RM). * sig.
main effect (p < 0.05)
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aptations beyond those attained with casein and whey protein supplementation.
This appears to be the case for either body composition (see Table 2), muscular
performance (see Table 3), or cellular and molecular adaptations (see Tables 47).
The effectiveness of the training program is evident based on the significant main
effect increase over time for body mass and bone-free lean body mass (see Table
2), and for most of the kinetic variables (i.e., force, velocity, and power; see Table
3). The efficacy of the readily absorbed (Boirie, Dangin, Gachon et al. 1997) casein
and whey protein supplementation for enhancing muscular performance (Lands,
Gray, and Smountas 1999), increasing circulating concentrations of amino acids,
and positively influencing protein metabolism (Jenkin, Yang, and Anderson 1979;
Reecy, Williams, Kerley et al. 1996; Silk, Clark, Marrs et al. 1975) has been re-
ported in the literature. Due to their cost and effectiveness, casein and whey pro-
tein supplements are readily available commercially.
Colostrum supplementation has been suggested as an ergogenic supplement
based on several physiological mechanisms. Colostrum has been reported to en-
hance protein synthesis (Burrin, Shulman, Reeds et al. 1992) and increase lean
Table 4
Relative mATPase Fiber Types (%; Mean ± SE)
Fiber Type Test Myo + Col Myo + C&W Col + C&W Cas + Whey
Type I Pre 46.8 ± 7.0 58.7 ± 17.7 51.1 ± 6.2 50.8 ± 4.5
Post 44.9 ± 5.1 53.5 ± 10.0 46.2 ± 5.0 45.0 ± 3.7
Type IC Pre 0.7 ± 0.6 0.3 ± 0.2 0.7 ± 0.3 0.3 ± 0.1
Post 1.9 ± 0.6 0.9 ± 0.7 1.3 ± 0.4 0.9 ± 0.4
Type IIC/AC Pre 2.8 ± 0.6 0.7 ± 0.4 0.6 ± 0.3 0.2 ± 0.1
Post 1.9 ± 0.9 0.1 ± 0.1 2.6 ± 1.1 0.4 ± 0.2
Type IIA Pre 35.7 ± 10.9 26.0 ± 4.0 23.8 ± 4.2 30.2 ± 1.7
Post 34.5 ± 15.1 30.9 ± 9.0 30.2 ± 5.8 36.3 ± 4.1
Type IIAB Pre 3.7 ± 1.8 6.8 ± 3.3 11.0 ± 1.6 9.0 ± 1.2
Post 7.0 ± 2.5 8.4 ± 3.4 18.1 ± 2.5 7.5 ± 1.3
Type IIB Pre 10.2 ± 4.5 7.5 ± 4.4 12.8 ± 4.3 9.5 ± 2.5
Post 19.8 ± 3.3 6.2 ± 3.1 11.6 ± 2.4 9.9 ± 3.1
 Note: Myo + Col = MyoVive + colostrum group (n = 4), Myo + C&W = MyoVive
+ casein & whey group (n = 4), Col + C&W = bovine colostrum + casein & whey group (n
= 6), and Cas + Whey = casein & whey only group (n = 5). No sig. differences (p > 0.05)
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body mass (Antonio, Sanders, and VanGammern 2001). Several mechanisms are
possible for these effects, including elevating circulating concentrations of IGF-1
(Mero, Miikkulainen, Riski et al. 1997), altering immune system function via
cytokines (Bocci, von Bremen, Corradeschi et al. 1991), and acting as an antioxi-
dant (Buescher and McIlhern 1988). None of these variables was measured in the
present study, but the apparent lack of a greater training effect due to colostrum
ingestion suggests that none of these mechanisms was a contributing factor. Addi-
tionally, no performance measures appeared to be influenced by the colostrum
supplementation. Although some previous research suggests an ergogenic effect
of colostrum supplementation (Brinkworth, Buckley, Bourdon et al. 2002; Buckley,
Abbott, Brinkworth et al. 2002; Coombes, Conacher, Austen et al. 2002; Hofman,
Smeets, Verlaan et al. 2002), the most common result suggested is enhanced re-
covery, perhaps due to an augmented lactate buffering mechanism (Brinkworth,
Buckley, Bourdon et al. 2002; Buckley, Abbott, Brinkworth et al. 2002; Coombes,
Conacher, Austen et al. 2002). Although none of the performance measures used
in the present study was dependent on buffering capabilities, it was possible that
enhanced recovery could have affected the training sessions, resulting in a greater
training effect. The present data, however, do not support this scenario.
To the authors knowledge, no previous studies have examined the effect of
MyoVive supplementation on skeletal muscle responses to chronic resistance
exercise. Data exist suggesting a beneficial effect on myocardial function
(Jeejeebhoy, Keith, Freeman et al. 2002), possibly due to the effects of several
ingredients critical to aerobic metabolism (see Table 1). Perhaps the most likely
ergogenic ingredient in MyoVive is creatine monohydrate (Bemben, Bemben,
Table 5
Muscle Fiber Cross-Sectional Areas for the Major Fiber Types
(mm2; Mean ± SE)
Fiber Type Test Myo + Col Myo + C&W Col + C&W Cas + Whey
Type I Pre 4000 ± 681 4319 ± 357 4243 ± 695 5069 ± 431
Post 4044 ± 263 5244 ± 576 4676 ± 557 4820 ± 421
Type IIA Pre 5037 ± 842 6161 ± 1961 5428 ± 802 7908 ± 1042
Post 5293 ± 770 6790 ± 1308 6588 ± 529 7688 ± 1789
Type IIB Pre 3875 ± 1824 3355 ± 1317 4012 ± 689 6019 ± 665
Post 2952 ± 1009 3799 ± 1147 5171 ± 321 5271 ± 697
Note: Myo + Col = MyoVive + colostrum group (n = 4), Myo + C&W = MyoVive
+ casein & whey group (n = 4), Col + C&W = bovine colostrum + casein & whey group (n
= 6), and Cas + Whey = casein & whey only group (n = 5). No sig. differences (p > 0.05)
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Loftiss et al. 2001; Nissen and Sharp 2003). Although creatine monohydrate has
been associated with increased protein synthesis and mRNA (Willoughby and
Rosene 2001), increased lean mass (Bemben, Bemben, Loftiss et al. 2001; Nissen
and Sharp 2003), and enhanced muscular performance (Bemben, Bemben, Loftiss
et al. 2001; Nissen and Sharp 2003), such results are equivocal. It is possible that
the dosage in the present study was not adequate for an ergogenic effect, but pre-
vious use of such a dosing strategy suggests this should not be the case (Nissen
and Sharp 2003). It is possible that the training program was inadequate to pro-
duce the desired effect of creatine, but the fact that all the subject groups exhibited
strength and mass improvements suggests this is not the case.
Muscular performances were improved during the 12-week training program
for all subjects. Because approximately 10 RM loads were used for training (ap-
proximately 70%85% 1 RM), one might expect that the greatest improvements
would be observed for the 70% 1 RM load tests. The present data, however, sug-
gest that peak force, velocity, and power also were increased for 40% 1 RM loads,
and peak velocity and power were increased for 100% 1 RM loads. As has been
recently suggested, it appears that although improvements are typically specific to
training loads and velocities, this relationship is not absolute, and training effects
carry over somewhat to other velocities and loads (Cronin, McNair, and Marshall
2002). Additionally, it has been reported recently that supervised resistance train-
ing sessions result in greater strength and body composition improvements when
compared with those training in an unsupervised environment (Mazetti, Kraemer,
Volek et al. 2000). As such, it is possible that none of the subjects in the present
study achieved optimal improvements in the measured variables. It is now appar-
ent that future research must address this concern.
Table 6
Relative Fiber Type Areas for the Major Fiber Types (%; mean ± SE)
Fiber Type Test Myo + Col Myo + C&W Col + C&W Cas + Whey
Type I Pre 49.5 ± 9.0 57.9 ± 5.2 53.6 ± 6.8 47.1 ± 3.2
Post 46.3 ± 5.6 56.5 ± 9.8 44.9 ± 5.8 40.0 ± 3.5
Type IIA Pre 41.3 ± 11.0 36.3 ± 5.4 33.4 ± 6.1 42.8 ± 2.1
Post 44.5 ±  4.9 39.7 ± 9.7 41.6 ± 6.7 50.5 ± 4.5
Type IIB Pre   9.2 ± 3.3   5.8 ± 3.2 13.0 ± 4.7 10.1 ± 2.5
Post   9.2 ± 3.1   3.8 ± 2.1 13.5 ± 3.2 29.4 ± 3.0
Notes: Myo + Col = MyoVive + colostrum group (n = 4), Myo + C&W = MyoVive
+ casein & whey group (n = 4), Col + C&W = bovine colostrum + casein & whey group (n
= 6), and Cas + Whey = casein & whey only group (n = 5). No sig. differences (p > 0.05)
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The muscle fiber and MHC data indicate no differential effect of any of the
supplements in conjunction with a 12-week resistance exercise program. Untrained
men and women beginning a structured resistance exercise program typically ex-
hibit a transition from type IIB to IIA fiber types, an increase in fiber cross-sec-
tional areas, as well as a protein expression shift from MHC IIb to IIa (Fry,
Allemeier, and Staron 1994; Staron and Johnson 1993; Staron, Karapondo, Kraemer
et al. 1994; Staron, Malicky, Leonardi et al. 1990). Elite competitive weightlifters
and power lifters, on the other hand, actually exhibit little or no type IIB fibers or
MHC IIb (Fry, Staron, Hagerman et al. in press; Fry, Webber, Weiss et al. in
press). Although bone-free lean mass increased for all groups in the present study,
such hypertrophy was not evident at the cellular level. It is possible that the en-
hanced lean mass was due to an increased intracellular fluid component, which
has been suggested as a mechanism of adaptation for creatine, but such a response
has not been suggested for the other supplements used. It also is possible that
much of the increase in lean mass occurred in the upper body, whereas the biop-
sies were simply indicative of adaptations of the lower body.
Another important consideration is that the present study included both men
and women in all subject groups. Gender differences for absolute strength are well
documented, although the differences disappear or greatly diminish when adjusted
for lean mass (Staron, Karapondo, Kraemer et al. 1994). Although it has been
reported that there is no gender difference in the % fiber types, there may be a
Table 7
Relative Myosin Heavy Chain (MHC) Expression (%; Mean ± SE)
MHC Test Myo + Col Myo + C&W Col + C&W Cas + Whey
Isoform
MHC I Pre 35.3 ± 6.9 51.2 ± 6.9 41.8 ± 5.6 48.0 ± 6.1
Post 41.8 ± 6.8 48.6 ± 6.8 36.2 ± 5.6 50.2 ± 6.1
MHC IIa Pre 53.8 ± 5.6 37.7 ± 5.6 45.3 ± 4.6 40.5 ± 5.1
Post 45.2 ± 6.3 39.6 ± 6.3 50.7 ± 5.1 39.5 ± 5.6
MHC IIb Pre 10.9 ± 2.6 11.1 ± 2.6 12.7 ± 2.1 10.5 ± 2.3
Post 13.0 ± 2.8 11.8 ± 2.8 13.1 ± 2.2 10.3 ± 2.5
________________________________________________________________________
Note: Myo + Col = MyoVive + colostrum group (n = 4), Myo + C&W =
MyoVive + casein & whey group (n = 4), Col + C&W = bovine colostrum +
casein & whey group (n = 6), and Cas + Whey = casein & whey only group (n =
5). No sig. differences (p > 0.05)
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gender difference in the sizes of the various fiber types (Staron, Hagerman, Hikida
et al. 2000). Several factors must be considered here. First, when fiber data were
reported as % change scores, thus examining relative changes, no group differ-
ences were observed (data not reported). Such a treatment of the data would re-
duce or eliminate the effect of gender differences. And second, when performance
data were adjusted for body mass or bone-free lean mass, no group differences
were observed (data not reported). Thus, no matter how the data were treated, no
differential effects of supplementation were observed. As a further precaution due
to the group sample sizes, effect sizes were calculated for all comparisons (Cohen
1977; Vincent 1995; Wilson, Becker, and Tinker 1995), resulting in only small
effect sizes.
In total, the results of the present study suggest that any ergogenic effect of
MyoVive or colostrum supplementation is not different from that of casein and
whey protein supplementation. As such, within the scope of the present study,
these data do not support supplementing with either MyoVive or colostrum in
replacement of casein and whey protein supplementation. Further study would be
necessary to more clearly determine the role of training status and the acute train-
ing variables (i.e., choice of exercise, order of exercise, volume, intensity, and
interset rest intervals).
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